Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 335

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 335
---
: Each holder of Series A Preferred
Stock may convert at any time, all, or any part, of the outstanding Series A Preferred Stock into shares of the Common Stock at the initial
“Conversion Price” of $1,000.00, which is subject to customary adjustments for stock splits. The Company’s Board of
Directors has the right, at any time, with the written consent of the Required Holders (as defined in the Certificate of Designation
of Preferences, Rights and Limitations of the Series A Convertible Preferred Stock (the “Series A Certificate of Designations”)),
to lower the fixed conversion price to any amount and for any period of time. If 90 days or 180 days following the occurrence of the
effective date of the registration statement filed pursuant to the PIPE Registration Rights Agreement, the Conversion Price then in effect
is greater than the greater of $100.00 and the Market Price then in effect (the “Adjustment Price”), the Conversion Price
shall automatically lower to the Adjustment Price. In connection with such adjustment provisions, the Conversion Price has been reset
to $100.00.

<div align='center'>F-15</div>

Alternate Conversion: Following the occurrence
and during the continuance of a Trigger Event (as defined below), each holder may alternatively elect to convert the Series A Preferred
Stock at the “Alternate Conversion Price” equal to the lesser of the Conversion Price and the greater of $100.00 (the “Conversion
Price Floor”) or 80% of the 5-day volume weighted average price of a share of Common Stock. Trigger events include customary terms
related to exchange listing, registration rights, failure to deliver shares on conversion or exercise of derivative instruments, or insolvency.
Notwithstanding the Conversion Price Floor, if the Conversion Price Floor is greater than 80% of the 5-day volume weighted average price
of a share of Common Stock, then the Conversion Amount (as defined in the Certificates of Designations, (as defined below) is increased
by a multiplier resulting in the convertibility of the shares of Series A Preferred Stock into the number of shares of Common Stock that
would have been issuable if the Alternate Conversion Price had been equal to such lower volume weighted average price. Such multiplier
has been in effect since the registration statement for the resale of shares of Common Stock issuable upon conversion of the Series A
Preferred Stock was declared effective on July 5, 2024 because such effectiveness was after the applicable deadline therefore and,